David Toung
Stock Analyst at Argus Research
(4.28)
# 442
Out of 4,711 analysts
116
Total ratings
65.22%
Success rate
10.4%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie | Upgrades: Buy | n/a | $175.58 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $118.28 | +5.68% | 9 | Sep 11, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $570 → $600 | $500.13 | +19.97% | 7 | Jul 17, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Hold | n/a | $185.77 | - | 5 | Jun 28, 2024 | |
| AMGN Amgen | Maintains: Buy | $300 → $340 | $263.38 | +29.09% | 10 | Jun 27, 2024 | |
| MCK McKesson | Maintains: Buy | $570 → $670 | $579.74 | +15.57% | 6 | Jun 24, 2024 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Buy | $150 | $107.12 | +40.03% | 7 | May 21, 2024 | |
| LLY Eli Lilly | Maintains: Buy | $770 → $840 | $767.76 | +9.41% | 3 | May 14, 2024 | |
| HOLX Hologic | Maintains: Buy | $89 → $95 | $71.65 | +32.59% | 1 | May 9, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $80 → $110 | $78.91 | +39.40% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $228.61 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $26.36 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $247.10 | - | 8 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $540 → $550 | $524.05 | +4.95% | 6 | Nov 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $21.80 | - | 1 | Jun 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $364.60 | -14.98% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $303.62 | +2.10% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $524.43 | -38.98% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $114.23 | +18.18% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $92.57 | -18.98% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $57.33 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $98.05 | +12.19% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $81.03 | +103.63% | 6 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.44 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $73.17 | +67.42% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $65.35 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $97.11 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $144.47 | +7.29% | 4 | Mar 27, 2020 |
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $175.58
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $118.28
Upside: +5.68%
UnitedHealth Group
Jul 17, 2024
Maintains: Buy
Price Target: $570 → $600
Current: $500.13
Upside: +19.97%
Charles River Laboratories International
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $185.77
Upside: -
Amgen
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $263.38
Upside: +29.09%
McKesson
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $579.74
Upside: +15.57%
Zimmer Biomet Holdings
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $107.12
Upside: +40.03%
Eli Lilly
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $767.76
Upside: +9.41%
Hologic
May 9, 2024
Maintains: Buy
Price Target: $89 → $95
Current: $71.65
Upside: +32.59%
GE HealthCare Technologies
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $78.91
Upside: +39.40%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $228.61
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $26.36
Upside: -
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $247.10
Upside: -
Nov 6, 2023
Maintains: Buy
Price Target: $540 → $550
Current: $524.05
Upside: +4.95%
Jun 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $21.80
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $364.60
Upside: -14.98%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $303.62
Upside: +2.10%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $524.43
Upside: -38.98%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $114.23
Upside: +18.18%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $92.57
Upside: -18.98%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $57.33
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $98.05
Upside: +12.19%
Aug 27, 2021
Maintains: Buy
Price Target: $150 → $165
Current: $81.03
Upside: +103.63%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $9.44
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $73.17
Upside: +67.42%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $65.35
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $97.11
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $144.47
Upside: +7.29%